title: Update on the treatment of hypothyroidism.
abstract: OBJECTIVE
  Differentiated thyroid cancer is a malignancy that is rapidly increasing in frequency. As thyroidectomy plays a central role in the treatment of thyroid cancer, it is incumbent on physicians treating this patient group to be well versed in the intricacies of treating hypothyroidism.
  
  
  RESULTS
  Treatment of hypothyroidism may be refined by careful attention to dose selection, monitoring of therapy and achievement of thyrotropin goals that are specific to the individual patient's overall clinical situation. These goals are common not only to patients with a sole diagnosis of hypothyroidism, as discussed in the recent American Thyroid Association Guidelines, but also to patients with hypothyroidism in the setting of thyroid cancer. Several recent studies have illuminated our understanding of the benefits and risks of thyrotropin suppression therapy in patients with differentiated thyroid cancer. Multiple studies of combination therapy with levothyroxine and liothyronine for treating hypothyroidism have not led to a clear conclusion about its benefits over levothyroxine monotherapy. Animal studies have advanced our understanding of the altered serum and tissue milieu that characterizes levothyroxine monotherapy. Crossing the bridge from this translational research into clinical research using sustained release triiodothyronine preparations may ultimately enhance the health of our patients.
  
  
  CONCLUSIONS
  Continued refinement of our understanding of thyroid status and our ability to flawlessly implement thyroid hormone replacement is an active area of research.
authors.affiliation: Division of Endocrinology, Georgetown University, Washington, District of Columbia, USA.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Jonklaas
mesh_terms: D000367:Age Factors; D000818:Animals; D001835:Body Weight; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy* / Q000209:etiology; D011788:Quality of Life; D013964:Thyroid Neoplasms / Q000601:surgery*; D013965:Thyroidectomy / Q000009:adverse effects* / Q000379:methods; D013972:Thyrotropin / Q000097:blood*; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D013972:Thyrotropin; D013974:Thyroxine